What new drugs should you know about from the second quarter of 2018? Scroll through our quick slideshow to find out.
Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows
Elinzanetant reduced VMS frequency and intensity, and improved sleep and quality of life, according to the meta-analysis to be presented at the ACOG 2025 meeting.
Weekly Dose: A Roundup of Top Stories for Primary Care Physicians
PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.
ACOG Issues Consensus Guidance to Improve Pain Control During In-Office Gynecologic Procedures
Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast
“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.
Majority of Pregnant Patients Accepted RSV Protection in Vaccine's First Season
Two-thirds of pregnant individuals opted for either maternal vaccination against RSV or for neonatal monoclonal antibody therapy and for other vaccines recommended in pregnancy.
ACOG 2025: Menopause and Vasomotor Symptoms Preview
A preview of sessions covering Menopause and Vasomotor Symptoms during ACOG 2025 in Minneapolis, MN.